3036 — Alconix Balance Sheet
0.000.00%
- ¥79bn
- ¥119bn
- ¥197bn
Annual balance sheet for Alconix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 26,689 | 26,993 | 21,471 | 18,762 | 21,537 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 58,773 | 61,679 | 56,155 | 62,404 | 67,620 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 135,119 | 144,212 | 132,549 | 144,374 | 162,291 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25,061 | 31,993 | 31,737 | 37,374 | 39,401 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 176,437 | 191,890 | 182,890 | 196,634 | 222,427 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 94,643 | 100,348 | 89,693 | 103,196 | 120,429 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 119,568 | 129,366 | 117,141 | 126,932 | 143,169 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 56,869 | 62,524 | 65,749 | 69,702 | 79,258 |
| Total Liabilities & Shareholders' Equity | 176,437 | 191,890 | 182,890 | 196,634 | 222,427 |
| Total Common Shares Outstanding |